controlled hypertensive patients.
Conditions
Interventions
Intervention 1: Intervention group: 16 patients with injection of perilocain 3%+ felypressin daru pakhsh. Intervention 2: Intervention group: 16 patients with mepivacain hydrochlorid 3% eksir.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with controlled hypertension who are willing to cooperate
Exclusion criteria
Exclusion criteria: Patients with a history of drug allergy, a history of asthma, nasal polyps, bronchospasm or angioedema, heart failure or liver failure, pregnancy, patients with idiopathic or congenital methemoglobinemia, patients with bleeding disorders, patients taking anticoagulant drugs failure to sign a written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Before intervention and 10 , 30 minute after. Method of measurement: Pulse oximeter.;Blood pressure. Timepoint: Before intervention and 10 , 30 minute after. Method of measurement: Blood pressure monitor.;Blood oxygen saturation. Timepoint: Before intervention and 10 , 30 minute after. Method of measurement: Pulse oximeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stress score. Timepoint: before and after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Homayoun
Shiraz University of Medical Sciences
Outcome results
None listed